Bone safety of dual-release hydrocortisone in patients with hypopituitarism.

Frara, Stefano; Chiloiro, Sabrina; Porcelli, Teresa; Giampietro, Antonella; Mazziotti, Gherardo; De Marinis, Laura; Giustina, Andrea

Frara, Stefano; Chiloiro, Sabrina; Porcelli, Teresa; Giampietro, Antonella; Mazziotti, Gherardo; De Marinis, Laura; Giustina, Andrea.

Afiliación

Frara S; Chair of Endocrinology, Università Vita-Salute San Raffaele, Milan, Italy.
Chiloiro S; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
Porcelli T; Montichiari Hospital, ASST Spedali Civili of Brescia, Brescia, Italy.
Giampietro A; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
Mazziotti G; Endocrine Unit, ASST Carlo Poma, Mantua, Italy.
De Marinis L; Pituitary Unit, Catholic University of the Sacred Heart, Rome, Italy.
Giustina A; Chair of Endocrinology, Università Vita-Salute San Raffaele, Milan, Italy. giustina.andrea@hsr.it.

Endocrine ; 60(3): 528-531, 2018 06.

Article en En | MEDLINE | ID: mdl-29313195

Asunto(s)

Hidrocortisona/efectos adversos; Hipopituitarismo/tratamiento farmacológico; Osteoporosis/inducido químicamente; Adulto; Anciano; Femenino; Humanos; Hidrocortisona/uso terapéutico; Masculino; Persona de Mediana Edad

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Osteoporosis / Hidrocortisona / Hipopituitarismo Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Endocrine Asunto de la revista: ENDOCRINOLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google